Physician profile
Stuart Shah
NPI 1700271343
$8,117.54
in general payments reported to CMS, 2019-2025
35 companies · $2,242 in 2025
The $2,242 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $188 · 2023: $2,465 · 2024: $3,224 · 2025: $2,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,731 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,730.68 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,997.95 | 2023-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $1,079.80 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $716.79 | 2022-2025 | Ofev, Jascayd, Stiolto Respimat |
| Ethicon INC. | $367.62 | 2024-2025 | Monarch Platform |
| Insmed, INC. | $359.30 | 2022-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $328.99 | 2023-2025 | Glassia, Cuvitru |
| Amgen INC. | $301.09 | 2023-2025 | Tezspire |
| Inogen, INC. | $233.22 | 2023-2025 | Inogen |
| Regeneron Healthcare Solutions, INC. | $229.04 | 2023-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $226.73 | 2023-2025 | Opsumit, Uptravi |
| Jazz Pharmaceuticals INC. | $195.48 | 2023-2025 | Xywav |
| Mylan Specialty L.P. | $191.05 | 2023-2024 | Yupelri |
| Shionogi INC | $158.26 | 2023-2025 | Fetroja |
| Pulmonx Corporation | $147.23 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Philips North America LLC | $140.24 | 2023-2024 | (Ak6) Vest Therapy |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $130.30 | 2025 | |
| Mallinckrodt Hospital Products INC. | $128.28 | 2023-2024 | Acthar, Terlivaz |
| Genzyme Corporation | $122.81 | 2023-2025 | |
| United Therapeutics Corporation | $117.45 | 2023-2025 | Tyvaso, Tyvaso |
| Inspire Medical Systems, INC. | $105.61 | 2023-2025 | Inspire |
| Ani Pharmaceuticals, INC. | $104.38 | 2023-2024 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $87.22 | 2025 | |
| Janssen Pharmaceuticals, INC | $82.99 | 2023 | Xarelto |
| Viatris Specialty LLC | $81.43 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $78.17 | 2023-2024 | Recarbrio, Zerbaxa, Dificid |
| Axsome Therapeutics, INC. | $75.36 | 2024-2025 | Sunosi |
| Intuitive Surgical, INC. | $62.97 | 2022 | |
| Lilly USA, LLC | $56.68 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $49.21 | 2024 | |
| Grifols USA, LLC | $45.20 | 2024-2025 | Xembify, Gamunex-C |
| Resmed Corp | $34.40 | 2023 | |
| Baxter Healthcare | $31.78 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Idorsia Pharmaceuticals US INC | $17.84 | 2023 | Quviviq |
| Electromed, INC. | $16.93 | 2024 | Smartvest |
| Csl Behring | $15.74 | 2025 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.